Literature DB >> 10566596

Frequent loss of heterozygosity on chromosome 6p in uveal melanoma.

J A Metzelaar-Blok1, M J Jager, P H Moghaddam, A R van der Slik, M J Giphart.   

Abstract

Lack of expression of HLA class I antigens is frequently observed on primary uveal melanoma, and is correlated with improved patient survival. Several mechanisms may contribute to the observed loss of HLA class I expression, including changes at the DNA level. In this study, we used microsatellite analysis as a molecular genetic approach to examine loci on chromosome 6p for loss of heterozygosity (LOH). Three pairs of microsatellite markers were used to screen 20 formalin-fixed, paraffin-embedded uveal melanomas for LOH on the short arm of chromosome 6. In all cases, normal adjacent scleral tissue was used as a control. We identified LOH in eleven cases from microsatellite locus D6S105 to the telomere, in eight cases from microsatellite locus D6STNFa to the telomere (area includes D6S105), and in seven cases from microsatellite locus D6S291 to the end of chromosome 6p (includes D6STNFa and D6S105). In seven cases, retention of heterozygosity was found at all three loci using these primers. Our results suggest that loss of heterozygosity on chromosome 6p is a common feature in uveal melanoma. We did not find a correlation between the presence of LOH and locus-specific HLA-A and -B expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566596     DOI: 10.1016/s0198-8859(99)00067-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.

Authors:  T Huibertus van Essen; Sake I van Pelt; Inge H G Bronkhorst; Mieke Versluis; Fariba Némati; Cécile Laurent; Gregorius P M Luyten; Thorbald van Hall; Peter J van den Elsen; Pieter A van der Velden; Didier Decaudin; Martine J Jager
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 2.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

Review 3.  Role of Natural Killer Cells in Uveal Melanoma.

Authors:  Asad Javed; Mohammed Milhem
Journal:  Cancers (Basel)       Date:  2020-12-09       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.